Related Experiment Videos
[Malignant thymoma associated with severe aplastic anaemia]
O M Escobosa Sánchez1, A Herrero Hernández, T Acha García
1Unidad de Oncología Infantil, Hospital Materno-Infantil, Carlos Haya, Málaga, España. olmaes01@hotmail.com
Anales De Pediatria (Barcelona, Spain : 2003)
|January 29, 2009
Summary
Malignant thymoma is rare in children and can cause serious blood disorders. This case highlights a severe aplastic anemia complication following thymoma treatment in a pediatric patient.
Area of Science:
- Pediatric Oncology
- Hematology
- Neoplasms
Background:
- Malignant thymoma is an exceptionally rare pediatric neoplasm.
- Often presents with paraneoplastic syndromes, notably myasthenia gravis.
- Hematological abnormalities like aplastic anemia can occur.
Observation:
- A 12-year-old boy with a large malignant thymoma underwent chemotherapy and surgery.
- Developed severe aplastic anemia post-operatively.
- Showed a poor response to immunosuppressive therapy.
Findings:
- The patient experienced a severe aplastic anemia complication after thymoma treatment.
- Treatment with immunosuppressive therapy was largely ineffective.
- Massive pulmonary bleeding occurred as a subsequent complication.
Implications:
- This case underscores the potential for severe hematological complications in pediatric malignant thymoma.
- Highlights challenges in managing aplastic anemia secondary to thymoma.
- Suggests the need for careful monitoring and tailored treatment strategies in pediatric thymoma patients.
Related Concept Videos
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...